23-Jan-2026 12:00 PM CST - Benzinga Looking Into Biogen Inc's Recent Short Interest Biogen Inc's (NYSE: BIIB) short interest as a percent of float has fallen 32.24% since its last report. According to exchange reported data, there are now 4.47 million shares sold short, which is 3.93% of all regular shares that are available for trading.
11-Jan-2026 10:05 PM CST - Yahoo Finance UK 3 Reasons to Sell BIIB and 1 Stock to Buy Instead The past six months have been a windfall for Biogen's shareholders. The company's stock price has jumped 41.7%, setting a new 52-week high of $188.65 per share. This was partly thanks to its solid quarterly results,
10-Jan-2026 2:22 PM CST - Yahoo Finance Here's What Analysts Think About Biogen Inc. (BIIB) Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Biogen Inc. (NASDAQ:BIIB) received several rating updates on January 8. Truist lifted the price target on the stock to $190 from $142 but maintained a Hold rating,
30-Dec-2025 6:57 AM CST - Seeking Alpha Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge Discover why Biogen Inc.'s stock surged 15% in 2025, driven by Skyclarys sales. Explore its strong growth potential and undervalued P/E. Click for this BIIB update.
17-Dec-2025 6:42 PM CST - Yahoo Finance Biogen (BIIB): Reassessing Valuation After a Recent 3-Month Share Price Rebound Biogen (BIIB) has quietly outperformed the market over the past 3 months, with shares up about 20%. This performance has put the stock back on investor radars after a stretch of weaker multi year returns.
Latest BIIB Trades by Congress Members
15-MAY-2025 - Rob Bresnahan, PA (District 8) purchased between $1,001 and $15,000.
23-Jan-2026 12:00 PM CST - Benzinga Looking Into Biogen Inc's Recent Short Interest Biogen Inc's (NYSE: BIIB) short interest as a percent of float has fallen 32.24% since its last report. According to exchange reported data, there are now 4.47 million shares sold short, which is 3.93% of all regular shares that are available for trading.
11-Jan-2026 10:05 PM CST - Yahoo Finance UK 3 Reasons to Sell BIIB and 1 Stock to Buy Instead The past six months have been a windfall for Biogen's shareholders. The company's stock price has jumped 41.7%, setting a new 52-week high of $188.65 per share. This was partly thanks to its solid quarterly results,
10-Jan-2026 2:22 PM CST - Yahoo Finance Here's What Analysts Think About Biogen Inc. (BIIB) Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Biogen Inc. (NASDAQ:BIIB) received several rating updates on January 8. Truist lifted the price target on the stock to $190 from $142 but maintained a Hold rating,
30-Dec-2025 6:57 AM CST - Seeking Alpha Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge Discover why Biogen Inc.'s stock surged 15% in 2025, driven by Skyclarys sales. Explore its strong growth potential and undervalued P/E. Click for this BIIB update.
17-Dec-2025 6:42 PM CST - Yahoo Finance Biogen (BIIB): Reassessing Valuation After a Recent 3-Month Share Price Rebound Biogen (BIIB) has quietly outperformed the market over the past 3 months, with shares up about 20%. This performance has put the stock back on investor radars after a stretch of weaker multi year returns.
